KENNETH E. PHILLIPS, DO
Osteopathic Medicine at Yale Ave, Tulsa, OK

License number
Oklahoma 3874
Category
Osteopathic Medicine
Type
Emergency Medicine
Address
Address
6161 S Yale Ave DEPT ER, Tulsa, OK 74136
Phone
(918) 494-6528
(405) 749-4561 (Fax)
(405) 751-4664

Personal information

See more information about KENNETH E. PHILLIPS at radaris.com
Name
Address
Phone
Kenneth Phillips
47282 S County Road 205, Woodward, OK 73801

Professional information

See more information about KENNETH E. PHILLIPS at trustoria.com
Kenneth Edward Phillips Photo 1
Kenneth Edward Phillips, Tulsa OK

Kenneth Edward Phillips, Tulsa OK

Specialties:
Emergency Medicine Physician
Address:
6161 S Yale Ave, Tulsa, OK 74136
1400 E Downing St, Tahlequah, OK 74464


Kenneth E Phillips Photo 2
Dr. Kenneth E Phillips, Tahlequah OK - DO (Doctor of Osteopathic Medicine)

Dr. Kenneth E Phillips, Tahlequah OK - DO (Doctor of Osteopathic Medicine)

Specialties:
Emergency Medicine
Address:
1400 E Downing St, Tahlequah 74464
(918) 453-2101 (Phone), (918) 453-2103 (Fax)
6161 S Yale Ave, Tulsa 74136
(918) 494-6528 (Phone), (405) 749-4561 (Fax)
Certifications:
Emergency Medicine
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1400 E Downing St, Tahlequah 74464
6161 S Yale Ave, Tulsa 74136
Saint Francis Hospital
6161 South Yale Ave, Tulsa 74136
Education:
Medical School
Oklahoma State University / College of Osteopathic Medicine
Graduated: 2000


Kenneth Phillips Photo 3
Antiviral Supplement Formulations

Antiviral Supplement Formulations

US Patent:
2010011, May 6, 2010
Filed:
Oct 30, 2009
Appl. No.:
12/609120
Inventors:
Kenneth E. Phillips - Tulsa OK, US
Cynthia A. Winning - Parker CO, US
Assignee:
VYMEDIC, LLC - Parker CO
International Classification:
A61K 31/7048, A61K 31/70, C12N 5/00, A61P 31/12
US Classification:
514 27, 514 25, 435375
Abstract:
The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.